OxySure (OXYS) Appoints Territory Sales Managers in Midwest and Rocky Mountain Region

Report this content

Provides Market Update and Recent Sales Channel Progress

Frisco, Texas, September 9, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other medical device solutions today announced the appointment of two new Territory Sales Managers in Indiana and Colorado. The Company has been aggressively recruiting a nationwide direct sales team to complement and enhance its existing distribution sales channel, comprising in excess of fifty distribution partners.

“We are on track with the execution of our expansion plans and we are excited to expand our sales footprint to the Midwest and Rocky Mountain Regions,” stated Julian T. Ross, CEO of OxySure. “Our business is growing stronger than ever, and we believe our medical device platform – a real company, with real people, and real products, saving the lives of real patients, is a rare find for our long term supporters,” Ross added.

Further information regarding the most recent sales appointments are as follows:

* Tom Escher – Territory Manager, Indianapolis: Mr. Escher brings eighteen years of sales and management experience to OxySure.  He has worked with several organizations in the industrial safety market, most notably ten years with Draeger Safety, selling self-contained breathing apparatus and other safety equipment to fire departments, industrial accounts and municipalities. Other experience includes Donley Safety and 5 Alarm Fire and Safety. As a multiple “Top Gun Sales Performance Award Winner,” Mr. Escher brings a lot of success and experience calling on the public access markets such as schools, government and municipal agencies.  He holds a Bachelor of Business Administration & Marketing degree from Robert Morris University in Pittsburgh, PA.

At OxySure Mr. Escher will focus on developing new resuscitation business within the municipal, corporate, public access and school markets, while also supporting and expanding our existing distribution partnerships in the Midwest.  He will be responsible for the states of Indiana, Ohio and Kentucky.

* Mark Grainger – Territory Manager, Denver: Mr. Grainger is joining OxySure following a successful four year career with Digital Ally, selling digital video equipment and software systems to law enforcement, fire departments and EMS agencies in CO, WY, MT and UT. Prior to Digital Ally, Mr. Grainger worked at Atronic Americas and Bally Gaming & Systems for seven years selling slot machine systems to casinos covering the western U.S.  Mr. Grainger also spent time as the Western Regional Manager at Southeastern Emergency Equipment selling defibrillators, pulse oximeters and respirators.  His successful track record includes both exceeding sales quotas and increasing territory revenue growth year over year.  Mr. Grainger holds a Bachelor of Science degree North Carolina State University. 

At OxySure, Mr. Grainger will also be responsible for the new business development in the pre-hospital and public access markets, while targeting new distribution partners throughout the Rocky Mountain States.  His territory will include CO, WY, MT and UT.

The Company’s sales teams and distribution partners are focused on deploying the OxySure Model 615 and other emergency medical solutions to be used to assist anyone in a medical emergency or other distress situation. Examples of such situations vary widely, and can include serious incidents such as cardiac arrest (in which OxySure is used post-resuscitation), as well as events such as asthma attacks, COPD exacerbations, allergy attacks, heat exhaustion, hypoxia/altitude sickness, migraine attacks, poisoning/overdose, diabetic emergencies, smoke inhalation, seizures, chest pain, fainting, dehydration, near drowning, hyperthermia, injury with trauma, and the treatment of shock. The standard of care in most medical emergencies is for first responders to provide supplemental oxygen to patients typically immediately upon arrival. OxySure’s Model 615 allows lay rescuers to begin sooner, thereby bridging the gap until professional responders arrive on the scene and can provide more advanced care.

“The OxySure Model 615 enables a loved one, bystander or even the person him/herself to provide oxygen, awaiting the arrival of emergency medical responders,” stated Dr. Vincent Mosesso, Medical Director of pre-hospital care services for the University of Pittsburgh Medical Center (UPMC), and also co-founder and Medical Director of the National Center for Early Defibrillation, now called Sudden Cardiac Arrest Association.

With these applications in mind, the sales teams create solutions for customers in numerous market segments, including the following:

  • Schools/School Districts
  • Colleges and Universities
  • Churches and Places of Worship
  • Golf Courses
  • MRI Centers (magnetic resonance imaging)
  • Corporate/Manufacturing
  • Government & Military
  • Airports
  • Oil & Gas Facilities
  • Utilities & Telecommunications
  • Municipal Facilities/Swimming Pools
  • Restaurants/Shopping
  • Recreational Vehicles
  • Marine (Yachts and Boats)
  • People with Asthma
  • People with COPD (chronic obstructive pulmonary disease)
  • People with Heart Conditions
  • General Medical Emergencies

A more comprehensive listing of customer segments and market-specific information can be found on OxySure’s website, located here:

http://www.oxysure.com/aed/index.php/who-needs-oxysure

About OxySure Systems, Inc.

OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments.  OxySure’s comprehensive emergency medical solutions also include other emergency response products such as automated external defibrillators (AEDs), pulse oximeters, and QuikClot Bleeding Control Systems and Hemostatic devices. www.OxySure.com

Forward-Looking Statements

Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2014.

Investor Contacts:

Renmark Financial Communications, Inc.

Bettina Filippone: bfilippone@renmarkfinancial.com

Tel.: (416) 644-2020 or (514) 939-3989

www.renmarkfinancial.com/

Redchip Companies, Inc.                

Jon Cunningham: jon@redchip.com  

800-733-2447, ext. 107                      

www.redchip.com/

Tags:

Documents & Links